David Cook - Publications

Institution:
AstraZeneca Pharmaceuticals , Hamilton, OH, United States

3 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2000 Cook DF, Wirtshafter D. Quinpirole attenuates the striatal immediate early gene expression, but not the hyperactivity, induced by the serotonin agonist RU-24969. Brain Research. 852: 247-54. PMID 10678749 DOI: 10.1016/S0006-8993(99)01993-9  0.515
1998 Cook DF, Wirtshafter D. Quinpirole attenuates striatal c-fos induction by 5-HT, opioid and muscarinic receptor agonists. European Journal of Pharmacology. 349: 41-7. PMID 9669494 DOI: 10.1016/S0014-2999(98)00184-8  0.509
1998 Wirtshafter D, Cook DF. Serotonin-1B agonists induce compartmentally organized striatal Fos expression in rats. Neuroreport. 9: 1217-21. PMID 9601697 DOI: 10.1097/00001756-199804200-00047  0.519
Show low-probability matches.